Skip to content
Telix Pharmaceuticals Limited icon

Telix Pharmaceuticals Limited

TLXStocksBiotechnologyAustraliaNasdaqUSD | AUD

Price

$30.01

Today

+0.4%

YTD

+0.0%

About

Telix Pharmaceuticals Ltd is a biopharmaceutical company based in Australia focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals. Its primary aim is to improve patient outcomes in oncology and rare diseases globally through advanced precision medicine. Operating within the healthcare sector, Telix Pharmaceuticals Ltd specialises in targeted radiopharmaceutical technologies. The company's innovative pipeline seeks to provide physicians with better tools for disease management, from imaging to treatment, ultimately enhancing patient care. Explore TLX share prices and other stocks on eToro. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for TLX (1D candles).

No daily candle data is currently available for this instrument.

Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-527.96
P/S (TTM)4.69
P/B (TTM)9.09
Market cap$3.78B
Cap tierMid-cap
Industry avg P/E-6.22

Profitability

Gross margin53.15%
EBIT margin2.19%
Net margin-1.17%
ROE-1.86%
ROA-0.67%

Earnings & Revenue

Revenue (TTM)$804.63M
Revenue growth (1Y)+55.7%
EPS (TTM)-$0.02
Free cash flow$-55.30M
Total debt$467.11M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.00
Employees1,184
Next earnings17 Feb '27
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.